Search

Michael Williams

Michael Williams is a senior pharmaceutical executive with significant global experience. He was chief operating officer at Intarcia Therapeutics. Prior to Intarcia Therapeutics, Mr Williams was head of global marketing at Takeda Pharmaceuticals. Before joining Takeda, he was vice president of global commercial development for Pfizer’s Primary Care Global Business Unit. He also played a significant leadership role in Pfizer’s acquisition of King Pharmaceuticals and on alliances with Bristol Myers Squibb, Boehringer Ingelheim, Janssen and Eisai. During his time at Bristol Myers Squibb, he assumed roles of increasing responsibility, notably as regional business lead for HIV where he was responsible for the commercial performance of the HIV franchise, as well as vice president for European marketing and operations.
Bio last updated 13 Oct 2018

Positions - Previous

PositionCompanyYearCompany's current rankWA staff
Non-Executive Director
Phylogica
Phylogica
2018 - 2018213

Total Shareholder Return as at 28/09/18

1 year TSR5 year TSR
35thSportsHero180%-39%
65thAusCann Group Holdings116%61%
567thPhylogica-23%17%
664thPLC Financial Solutions-39%-41%
739 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Revenue

211th↓AusCann Group Holdings$54k
212th↓Activistic$49k
213th↓Phylogica$48k
214th↓SportsHero$23k
215th-PLC Financial Solutions$20k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer